Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.19
+0.12 (1.32%)
Feb 21, 2025, 4:00 PM EST - Market closed
Amicus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 213.75 | 246.99 | 148.81 | 245.2 | 163.24 | Upgrade
|
Short-Term Investments | 36.19 | 39.21 | 144.78 | 237.3 | 320.03 | Upgrade
|
Cash & Short-Term Investments | 249.95 | 286.2 | 293.6 | 482.5 | 483.27 | Upgrade
|
Cash Growth | -12.67% | -2.52% | -39.15% | -0.16% | 6.74% | Upgrade
|
Receivables | 101.1 | 87.63 | 66.2 | 52.67 | 46.92 | Upgrade
|
Inventory | 118.78 | 59.7 | 23.82 | 26.82 | 19.56 | Upgrade
|
Prepaid Expenses | 34.91 | 49.53 | 40.21 | 34.85 | 29.72 | Upgrade
|
Total Current Assets | 504.74 | 483.06 | 423.82 | 596.83 | 579.47 | Upgrade
|
Property, Plant & Equipment | 51.66 | 57.98 | 60.31 | 63.08 | 67.16 | Upgrade
|
Goodwill | 197.8 | 197.8 | 197.8 | 197.8 | 197.8 | Upgrade
|
Other Intangible Assets | 17.2 | 20.49 | 23 | - | - | Upgrade
|
Long-Term Deferred Charges | - | - | - | 23 | 23 | Upgrade
|
Other Long-Term Assets | 13.64 | 18.55 | 19.24 | 24.43 | 19.1 | Upgrade
|
Total Assets | 785.03 | 777.88 | 724.17 | 905.14 | 886.52 | Upgrade
|
Accounts Payable | 12.95 | 15.12 | 15.41 | 21.51 | 17.06 | Upgrade
|
Accrued Expenses | 100.49 | 121.44 | 80.23 | 87.8 | 92.75 | Upgrade
|
Current Portion of Leases | 8.46 | 8.32 | 8.55 | 7.41 | 6.87 | Upgrade
|
Current Income Taxes Payable | 18.11 | 12.43 | 5.94 | 6.15 | - | Upgrade
|
Other Current Liabilities | 8.71 | 10.37 | 28.88 | 23.1 | 12.99 | Upgrade
|
Total Current Liabilities | 148.7 | 167.69 | 139.02 | 145.98 | 129.68 | Upgrade
|
Long-Term Debt | 390.11 | 387.86 | 391.99 | 389.36 | 389.25 | Upgrade
|
Long-Term Leases | 45.08 | 48.88 | 51.58 | 43.36 | 45.6 | Upgrade
|
Long-Term Unearned Revenue | - | - | - | 5.91 | 7.41 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 4.93 | 4.9 | Upgrade
|
Other Long-Term Liabilities | 7.1 | 13.28 | 18.53 | 8.24 | 23.3 | Upgrade
|
Total Liabilities | 590.99 | 617.71 | 601.12 | 597.77 | 600.14 | Upgrade
|
Common Stock | 2.94 | 2.92 | 2.82 | 2.81 | 2.65 | Upgrade
|
Additional Paid-In Capital | 2,926 | 2,836 | 2,665 | 2,595 | 2,309 | Upgrade
|
Retained Earnings | -2,740 | -2,684 | -2,532 | -2,296 | -2,045 | Upgrade
|
Comprehensive Income & Other | 5.17 | 5.31 | -12.02 | 5.06 | 20.61 | Upgrade
|
Shareholders' Equity | 194.05 | 160.17 | 123.05 | 307.37 | 286.38 | Upgrade
|
Total Liabilities & Equity | 785.03 | 777.88 | 724.17 | 905.14 | 886.52 | Upgrade
|
Total Debt | 443.64 | 445.06 | 452.12 | 440.13 | 441.73 | Upgrade
|
Net Cash (Debt) | -193.7 | -158.86 | -158.53 | 42.37 | 41.54 | Upgrade
|
Net Cash Growth | - | - | - | 1.99% | -82.87% | Upgrade
|
Net Cash Per Share | -0.64 | -0.54 | -0.55 | 0.16 | 0.16 | Upgrade
|
Filing Date Shares Outstanding | 300.12 | 295.38 | 282.71 | 280.03 | 264.32 | Upgrade
|
Total Common Shares Outstanding | 299.04 | 293.59 | 281.11 | 278.91 | 262.06 | Upgrade
|
Working Capital | 356.03 | 315.37 | 284.8 | 450.86 | 449.79 | Upgrade
|
Book Value Per Share | 0.65 | 0.55 | 0.44 | 1.10 | 1.09 | Upgrade
|
Tangible Book Value | -20.95 | -58.11 | -97.75 | 109.57 | 88.58 | Upgrade
|
Tangible Book Value Per Share | -0.07 | -0.20 | -0.35 | 0.39 | 0.34 | Upgrade
|
Land | - | - | - | 3.19 | 3.19 | Upgrade
|
Machinery | 25.13 | 24.15 | 23.63 | 25.62 | 23.94 | Upgrade
|
Construction In Progress | 0.26 | 3.81 | 4.16 | 8.23 | 5.87 | Upgrade
|
Leasehold Improvements | 32.36 | 28.03 | 24.16 | 24.17 | 24.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.